REVIEW Overlapping Protein Accumulation Pro fi les of CADASIL and CAA Is There a Common Mechanism Driving Cerebral Small-Vessel Disease?
暂无分享,去创建一个
[1] M. Verbeek,et al. Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage , 2020, Acta Neuropathologica Communications.
[2] M. Ivanova,et al. Thiol-mediated and catecholamine-enhanced multimerization of a cerebrovascular disease enriched fragment of NOTCH3 , 2020, Experimental Neurology.
[3] Sung-Chun Tang,et al. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL , 2020, Journal of Neuroinflammation.
[4] C. Haffner. Proteostasis in Cerebral Small Vessel Disease , 2019, Front. Neurosci..
[5] C. Sigurdson,et al. Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue , 2019, Nature Communications.
[6] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[7] A. Tuttolomondo,et al. β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage , 2018, Oncotarget.
[8] H. Vinters,et al. The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier , 2018, Neurobiology of Aging.
[9] Ying Sun,et al. Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types , 2018, Scientific Data.
[10] Michael M. Wang,et al. Redistribution of Mature Smooth Muscle Markers in Brain Arteries in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy , 2018, Translational Stroke Research.
[11] A. Smit,et al. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer’s disease , 2018, Acta neuropathologica communications.
[12] M. Dichgans,et al. CADASIL brain vessels show a HTRA1 loss-of-function profile , 2018, Acta Neuropathologica.
[13] Koji Ando,et al. A molecular atlas of cell types and zonation in the brain vasculature , 2018, Nature.
[14] J. Montaner,et al. Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL , 2017, International journal of molecular sciences.
[15] T. Kawano,et al. Serum amyloid P component: A novel potential player in vessel degeneration in CADASIL , 2017, Journal of the Neurological Sciences.
[16] Karsten Melcher,et al. Amyloid beta: structure, biology and structure-based therapeutic development , 2017, Acta Pharmacologica Sinica.
[17] C. Ayata,et al. Emerging concepts in sporadic cerebral amyloid angiopathy. , 2017, Brain : a journal of neurology.
[18] M. van Buchem,et al. TGFβ pathway deregulation and abnormal phospho‐SMAD2/3 staining in hereditary cerebral hemorrhage with amyloidosis‐Dutch type , 2017, Brain pathology.
[19] N. De Stefano,et al. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects , 2017, BMC Medicine.
[20] H. Boutin,et al. Early changes in extracellular matrix in Alzheimer's disease , 2017, Neuropathology and applied neurobiology.
[21] J. Attems,et al. Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy , 2016, Neuropathology and applied neurobiology.
[22] J. van der Grond,et al. Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL , 2016, Annals of clinical and translational neurology.
[23] R. Nitsch,et al. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer’s disease-related microvascular cerebral amyloid angiopathy , 2016, Acta Neuropathologica.
[24] H. Stöhr,et al. Reducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice , 2016, Annals of neurology.
[25] Guojun Bu,et al. The role of APOE in cerebrovascular dysfunction , 2016, Acta Neuropathologica.
[26] M. Nelson,et al. Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain? , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] Martin Dichgans,et al. Genetic factors in cerebral small vessel disease and their impact on stroke and dementia , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[28] M. Tamura,et al. Characteristic features and progression of abnormalities on MRI for CARASIL , 2015, Neurology.
[29] M. Dichgans,et al. Cysteine-Sparing CADASIL Mutations in NOTCH3 Show Proaggregatory Properties In Vitro , 2015, Stroke.
[30] Michael M. Wang,et al. The Small Leucine-Rich Proteoglycan BGN Accumulates in CADASIL and Binds to NOTCH3 , 2015, Translational Stroke Research.
[31] M. Yamada. Cerebral Amyloid Angiopathy: Emerging Concepts , 2015, Journal of stroke.
[32] E. Dere,et al. Hypertension Accelerates the Progression of Alzheimer-Like Pathology in a Mouse Model of the Disease , 2015, Hypertension.
[33] M. Geschwind,et al. Latent NOTCH3 epitopes unmasked in CADASIL and regulated by protein redox state , 2014, Brain Research.
[34] R. Carare,et al. The Cerebrovascular Basement Membrane: Role in the Clearance of β-amyloid and Cerebral Amyloid Angiopathy , 2014, Front. Aging Neurosci..
[35] Michael M. Wang,et al. Vascular accumulation of the small leucine-rich proteoglycan decorin in CADASIL , 2014, Neuroreport.
[36] M. Dichgans,et al. Sequestration of latent TGF-β binding protein 1 into CADASIL-related Notch3-ECD deposits , 2014, Acta neuropathologica communications.
[37] C. Feghali-Bostwick,et al. Fibroblasts in fibrosis: novel roles and mediators , 2014, Front. Pharmacol..
[38] A. Joutel,et al. Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model , 2014, Acta neuropathologica communications.
[39] John R. Yates,et al. Identification of Long-Lived Proteins Reveals Exceptional Stability of Essential Cellular Structures , 2013, Cell.
[40] A. Joutel,et al. Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. , 2013, Brain : a journal of neurology.
[41] Michael M. Wang,et al. Advanced Intimal Hyperplasia Without Luminal Narrowing of Leptomeningeal Arteries in CADASIL , 2013, Stroke.
[42] J. Attems,et al. Brain microvascular accumulation and distribution of the NOTCH3 ectodomain and granular osmiophilic material in CADASIL. , 2013, Journal of neuropathology and experimental neurology.
[43] J. Bol,et al. Tissue transglutaminase colocalizes with extracellular matrix proteins in cerebral amyloid angiopathy , 2013, Neurobiology of Aging.
[44] R. Carare,et al. Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid‐β from the mouse brain , 2013, Aging cell.
[45] Jean-Baptiste Michel,et al. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. , 2012, Cardiovascular research.
[46] Michael M. Wang,et al. Bidirectional encroachment of collagen into the tunica media in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy , 2012, Brain Research.
[47] À. Rovira,et al. MMP‐2/MMP‐9 Plasma Level and Brain Expression in Cerebral Amyloid Angiopathy‐Associated Hemorrhagic Stroke , 2012, Brain pathology.
[48] H. D. de Vries,et al. Neuroinflammation and Blood-Brain Barrier Changes in Capillary Amyloid Angiopathy , 2012, Neurodegenerative Diseases.
[49] Michael M. Wang. Notch signaling and Notch signaling modifiers. , 2011, The international journal of biochemistry & cell biology.
[50] Michael M. Wang,et al. von Willebrand Factor Permeates Small Vessels in CADASIL and Inhibits Smooth Muscle Gene Expression , 2011, Translational Stroke Research.
[51] E. Kremmer,et al. Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis. , 2011, Human molecular genetics.
[52] H. D. de Vries,et al. Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. , 2011, Antioxidants & redox signaling.
[53] S. Gygi,et al. Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease , 2011, Proceedings of the National Academy of Sciences.
[54] K. Jellinger,et al. Review: Sporadic cerebral amyloid angiopathy , 2011, Neuropathology and applied neurobiology.
[55] Huaxi Xu,et al. APP processing in Alzheimer's disease , 2011, Molecular Brain.
[56] S. Greenberg,et al. Prevalence of Superficial Siderosis in Patients with Cerebral Amyloid Angiopathy , 2010, Neurology.
[57] C. Ayata. CADASIL: experimental insights from animal models. , 2010, Stroke.
[58] J. Choi. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A Genetic Cause of Cerebral Small Vessel Disease , 2010, Journal of clinical neurology.
[59] A. Schedl,et al. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. , 2010, The Journal of clinical investigation.
[60] M. Dichgans,et al. CADASIL mutations enhance spontaneous multimerization of NOTCH3. , 2009, Human molecular genetics.
[61] M. Dichgans,et al. CADASIL , 2009, The Lancet Neurology.
[62] M. Dichgans,et al. Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. , 2009, Brain : a journal of neurology.
[63] L. Lue,et al. ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ1–40 Peptides , 2009, The Journal of Neuroscience.
[64] Berislav V. Zlokovic,et al. Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.
[65] G. Zipfel,et al. Cerebral Amyloid Angiopathy: Progressive Disruption of the Neurovascular Unit , 2009, Stroke.
[66] R O Weller,et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology , 2008, Neuropathology and applied neurobiology.
[67] R. Carare,et al. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. , 2008, Brain pathology.
[68] S. Salloway,et al. Cerebral Cortical Arteriolar Angiopathy, Vascular Beta-Amyloid, Smooth Muscle Actin, Braak Stage, and APOE Genotype , 2008, Stroke.
[69] Jin-Moo Lee,et al. Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ* , 2006, Journal of Biological Chemistry.
[70] D. Mann,et al. Relationships in Alzheimer's disease between the extent of Aβ deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen , 2006 .
[71] H. Markus,et al. The spatial distribution of MR imaging abnormalities in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and their relationship to age and clinical features. , 2005, AJNR. American journal of neuroradiology.
[72] P. Libby,et al. CADASIL mutations impair Notch3 glycosylation by Fringe. , 2005, Human molecular genetics.
[73] B. Klonjkowski,et al. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. , 2004, Genes & development.
[74] M. Viitanen,et al. Fibrosis and Stenosis of the Long Penetrating Cerebral Arteries: the Cause of the White Matter Pathology in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy , 2004, Brain pathology.
[75] M. Dichgans,et al. CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk. , 2004, Experimental cell research.
[76] Norman J Beauchamp,et al. White Matter Hyperintensity on Cranial Magnetic Resonance Imaging: A Predictor of Stroke , 2004, Stroke.
[77] K. Welsh-Bohmer,et al. Vascular Smooth Muscle Actin Is Reduced in Alzheimer Disease Brain: A Quantitative Analysis , 2004, Journal of neuropathology and experimental neurology.
[78] R. Weller,et al. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer’s disease Pro-CAA position statement , 2004, Neurobiology of Aging.
[79] T. Saido,et al. Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation , 2003, The Lancet.
[80] Eduardo A. Fierro. Structures , 2003, Composite Architecture.
[81] U. Lendahl,et al. A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[82] K. Arima,et al. Arterial Changes in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) in Relation to Pathogenesis of Diffuse Myelin Loss of Cerebral White Matter: Examination of Cerebral Medullary Arteries by Reconstruction of Serial Sections of an Autopsy Case , 2002, Stroke.
[83] G. Weinmaster,et al. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels , 2001, Mechanisms of Development.
[84] J. Wegiel,et al. Role of Perivascular Cells and Myocytes in Vascular Amyloidosis , 2000, Annals of the New York Academy of Sciences.
[85] M. Dichgans,et al. Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3v EGF-like repeat domains , 2000, European Journal of Human Genetics.
[86] F. Chapon,et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. , 2000, The Journal of clinical investigation.
[87] M. Hudon,et al. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[88] S. Downes,et al. Regulation of Cell Surface Tissue Transglutaminase: Effects on Matrix Storage of Latent Transforming Growth Factor-β Binding Protein-1 , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[89] Y. Olsson,et al. Amyloid angiopathy of the human brain: immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells , 1998, Acta Neuropathologica.
[90] M. Dichgans,et al. The phenotypic spectrum of CADASIL: Clinical findings in 102 cases , 1998, Annals of neurology.
[91] J. Weissenbach,et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients , 1997, The Lancet.
[92] R. Powers,et al. Transglutaminase activity is increased in Alzheimer's disease brain , 1997, Brain Research.
[93] G. Kopen,et al. Localization of transglutaminase in hippocampal neurons: implications for Alzheimer's disease. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[94] J. Weissenbach,et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia , 1996, Nature.
[95] T. Wisniewski,et al. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. , 1995, The Biochemical journal.
[96] M J Ball,et al. beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[97] O Almkvist,et al. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. , 1992, Archives of neurology.
[98] F. Tagliavini,et al. Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[99] M. Willingham,et al. An Immunoperoxidase Study of Senile Cerebral Amyloidosis with Pathogenetic Considerations , 1981, Journal of neuropathology and experimental neurology.
[100] F. Shimizu,et al. Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique , 1975, Acta Neuropathologica.
[101] S. Ropele,et al. Cortical Superficial Siderosis in Different Types of Cerebral Small Vessel Disease , 2017, Stroke.
[102] D. Dickson,et al. Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views. , 2008, International journal of clinical and experimental pathology.
[103] O. Bugiani,et al. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease , 2004, Acta Neuropathologica.
[104] F. Verrecchia,et al. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. , 2002, The Journal of investigative dermatology.
[105] P. Wesseling,et al. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. , 2001, Acta neuropathologica.
[106] D. Graham,et al. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. , 1999, Journal of neuropathology and experimental neurology.
[107] R O Weller,et al. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.
[108] R N Kalaria,et al. Cerebral vessels in ageing and Alzheimer's disease. , 1996, Pharmacology & therapeutics.
[109] G. Glenner,et al. Alzheimerʼs disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1988 .
[110] S. Stergiou,et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy revisited , 2020, Neurology: Genetics.